91 results
Page 4 of 5
10-K
EX-10.1
swk52 xrn3dyq
31 Mar 21
Annual report
4:30pm
10-K
EX-10.9
vexth gqy
31 Mar 21
Annual report
4:30pm
S-3
EX-4.4
ryu1z9ysk oynd6yf4
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.3
ncpunkglck7qmc3 e2m6
29 Jan 21
Shelf registration
4:48pm
S-3
egzky
29 Jan 21
Shelf registration
4:48pm
S-8
o344gg5bsi
22 Jan 21
Registration of securities for employees
4:15pm
8-K/A
EX-99.1
u9vz0d059nxxdl7
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
27rodct51
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-10.1
99pf3od25p
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.2
yacea4
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
8-K
EX-3.1
ogmba9dn4s vr
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
d677vvy4rmz77xpjlx
2 Nov 20
Prospectus supplement
12:00am